UUnited Kingdom Read More UK Approves Telix’s Prostate Cancer Imaging Agent Illuccix, Addressing Supply Shortage12.02.2025 Telix Pharmaceuticals (ASX: TLX, Nasdaq: TLX) has received approval from the UK Medicines…